CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Ajanta Pharma Ltd

Ajanta Pharma Ltd

BSE 532331 AJANTPHARM INE031B01049
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 500

Filing rhythm · 60 trading days

37 filings · 4 material · busiest 2026-07-30

What it files

Filings

37 in the window

  1. 19 August 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 19, 2026 for Ravi Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  2. 14 August 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Ravi Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  3. 5 August 2026

    General

    Participation In Investor Conference

    Pls find enclosed Intimation w.r.t participation in Investor Conference

    Company Update / General View filing →

  4. 3 August 2026

    Concall Transcript

    Earnings Call Transcript

    Pls find enclosed herewith Earning Call Transcript

    Company Update / Earnings Call Transcript View filing →

  5. 31 July 2026

    Newspaper Publication

    Newspaper Publication

    Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.

    Company Update / Newspaper Publication View filing →

  6. 30 July 2026

    Board Outcome

    Board Meeting Outcome for BM Outcome

    Board Meeting Outcome

    Board Meeting / Outcome of Board Meeting View filing →

  7. 30 July 2026

    Results

    Results For 30.06.2026

    Results of 30.06.2026.

    Result / Financial Results View filing →

  8. 30 July 2026

    Dividend

    Corporate Action-Board approves Dividend

    PFA Dividend Intimation

    Corp. Action / Dividend View filing →

  9. 30 July 2026

    Record Date

    Record Date Intimation For Dividend

    PFA record date intimation

    Corp. Action / Record Date View filing →

  10. 30 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    Pls find enclosed ESOP Allotment

    Company Update / Allotment of ESOP / ESPS View filing →

  11. 30 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Pls find enclosed Audio Recording of Earnings Call

    Company Update / Analyst / Investor Meet View filing →

  12. 29 July 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 29, 2026 for Aayush Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  13. 21 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Pls find enclosed Revised Investor Call Intimation

    Company Update / Analyst / Investor Meet View filing →

  14. 20 July 2026

    Board Meeting

    Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026.

    Ajanta Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Financial Results for the quarter ....

    Board Meeting / Board Meeting View filing →

  15. 20 July 2026

    Board Meeting

    Update on board meeting

    Ajanta Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Update on board meeting

    Board Meeting / Board Meeting View filing →

  16. 20 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Pls fine enclosed Investor Call Intimation

    Company Update / Analyst / Investor Meet View filing →

  17. 17 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Pls find enclosed voting and scrutinizer's report w.r.t to 47th AGM held on 16.07.2026.

    AGM/EGM / AGM View filing →

  18. 16 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Pls find enclosed AGM Proceedings

    AGM/EGM / AGM View filing →

  19. 14 July 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Ravi Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  20. 8 July 2026

    SAST

    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 08, 2026 for Aayush Agrawal, ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  21. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Pls find enclosed Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  22. 3 July 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Aayush Agrawal Trust ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  23. 3 July 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  24. 2 July 2026

    General

    Update On US FDA Inspection At Paithan Manufacturing Facility

    Pls find enclosed Reg 30 Intimation.

    Company Update / General View filing →

  25. 1 July 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 01, 2026 for Ravi Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  26. 26 June 2026

    Trading Window

    Closure of Trading Window

    Pls find enclosed Trading Window Closure Notice.

    Insider Trading / SAST / Closure of Trading Window View filing →

  27. 19 June 2026

    Newspaper Publication

    Newspaper Publication

    Pls find enclosed newspaper publication of AGM Notice

    Company Update / Newspaper Publication View filing →

  28. 19 June 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 19, 2026 for Ravi Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  29. 18 June 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Pls find enclosed herewith Annual Report for FY 2025-2026.

    Others / Reg. 34 (1) Annual Report View filing →

  30. 18 June 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    Pls find enclosed BRSR for FY 2026.

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  31. 17 June 2026

    Newspaper Publication

    Newspaper Publication

    Pls find enclosed notice published in newspapers intimating that the 47th AGM of the Company will be held on 16th July 2026.

    Company Update / Newspaper Publication View filing →

  32. 15 June 2026

    AGM / EGM

    Shareholders Meeting- 47Th Annual General Meeting On 16/07/2026

    Pls find enclosed herewith AGM Intimation

    AGM/EGM / AGM View filing →

  33. 15 June 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 15, 2026 for Aayush Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  34. 12 June 2026

    General

    Participation In Investor Conference

    Pls find enclosed intimation w.r.t participation in investor conference

    Company Update / General View filing →

  35. 9 June 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Gabs Investments Pvt Ltd

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  36. 9 June 2026

    SAST

    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Aayush Agrawal, trustee ....

    Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

  37. 9 June 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ravi Agrawal, Trustee Ravi Agrawal Trust

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →